Company profile: Contego Medical
1.1 - Company Overview
Company description
- Provider of novel embolic protection devices and integrated vascular intervention systems, including Paladin IEP carotid PTA balloons for protected stenting; Neuroguard IEP carotid stent and post-dilation systems; Excipio dual-mode thrombectomy devices with physician-controlled expandable baskets; and Vanguard IEP peripheral angioplasty balloons with integrated embolic protection.
Products and services
- Excipio Thrombectomy Devices: Dual-mode, physician-controlled assemblies featuring an expandable basket to capture and remove thrombus during vascular procedures, enabling targeted clot extraction with user-directed expansion
- Neuroguard IEP: Integrated carotid stent and post-dilation balloon product delivering embolic protection to treat carotid artery stenosis, capturing emboli during stenting and the subsequent post-dilation phase
- Paladin IEP: Integrated carotid PTA balloon system delivering embolic protection during carotid stenting procedures to reduce stroke risk, enabling angioplasty while intercepting debris generated throughout the intervention
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Contego Medical
Artegraft
HQ: United States
Website
- Description: Provider of biologic vascular grafts derived from bovine carotid arteries, processed and sold for implantation primarily in hemodialysis patients, offering surgeons a biological alternative to synthetic grafts.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Artegraft company profile →
Morphogen-IX
HQ: United Kingdom
Website
- Description: Provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Morphogen-IX company profile →
Ionetix
HQ: United States
Website
- Description: Provider of end-to-end radiopharmaceutical solutions for cardiac PET imaging, including N-13 Ammonia for myocardial perfusion; the ION-12SC compact superconducting cyclotron for on/near-campus N-13 production; Cardiac PET consultative services (layout, regulatory, camera/software, training); and targeted alpha therapy using Actinium-225 and Astatine-211 to target cancer cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ionetix company profile →
Transcatheter Technologies
HQ: Germany
Website
- Description: Provider of a unique, repositionable transcatheter aortic valve implantation system designed to increase the safety and durability of aortic valve implantation. Its TRINITY transcatheter aortic valve system is at the forefront of next-generation transcatheter valve implantation technology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Transcatheter Technologies company profile →
Wright Therapy
HQ: United States
Website
- Description: Provider of home compression therapy solutions and devices for treating lymphedema and chronic venous insufficiency, with a history of innovation including the first sequential gradient pneumatic compression device.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Wright Therapy company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Contego Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Contego Medical
2.2 - Growth funds investing in similar companies to Contego Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Contego Medical
4.2 - Public trading comparable groups for Contego Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →